Appendix E - National Coverage Determinations Manual / CERTAIN_DRUGS_DISTRIBUTED_BY_THE_NATIONAL_CANCER_INSTITUTE

Why This Topic Matters

It helps determine whether services associated with NCI-distributed cancer drugs may fall under Medicare coverage under the manual’s stated conditions. This is relevant for billing, compliance, and coverage review in oncology settings.

Article Sections

1. Certain Drugs Distributed by the National Cancer Institute

   Introduces the NCI drug distribution policy and the effective date context for the appendix entry. It outlines the general subject matter of the coverage guidance for cancer treatment drugs.

2. Eligibility and distribution controls

   Describes the broad administrative and reporting framework associated with receiving drugs through the NCI program. It references the organizations and oversight structure involved in the distribution process.

3. Coverage handling and coverage questions

   Addresses how intermediaries may consider coverage in the setting described by the manual and notes where questions may be taken for review. It also identifies the general type of administrative assistance referenced by the guidance.

4. Information source for Group C drugs

   Lists the office and location where information about the drugs may be obtained. This section serves as a contact and reference point within the appendix entry.